ACM
ONXX

Advent Capital Management’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Advent Capital Management’s Portfolio ONXX Stock Details ONXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-20,000
Closed -$1.74M – 604
2013
Q2 		$1.74M Buy
+20,000
New +$1.84M 0.03% 369

Other funds holding ONXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advent Capital Management's ONXX Position: Q3 2013 in Review

Advent Capital Management sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q3 2013, closing a stake of 20,000 shares — an estimated $1.74M sold.

Advent Capital Management first reported a position in ONXX in Q2 2013 and held it in 1 quarter. The position peaked at $1.74M in Q2 2013. 258 funds tracked by Wall St. Rank hold ONXX as of Q3 2013.

  • Advent Capital Management reported no remaining ONYX PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Advent Capital Management sold 20,000 ONYX PHARMACEUTICALS INC shares in Q3 2013, an estimated $1.74M.
  • Advent Capital Management first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Advent Capital Management's ONYX PHARMACEUTICALS INC position peaked at $1.74M in Q2 2013.
  • 258 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q3 2013.

Based on Advent Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.